The global epidemiology of SLE: narrowing the knowledge gaps.
Megan R W Barber, Titilola Falasinnu, Rosalind Ramsey-Goldman...
https://pubmed.ncbi.nlm.nih.gov/36987602/Actively Recruiting
Led by Foundation University Islamabad · Updated on 2026-10-29
3000
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are establishing a Lupus Registry in Pakistan to better understand systemic lupus erythematosus SLE, a complex autoimmune disease that affects people worldwide. This project focuses on gathering detailed information about how SLE appears and progresses specifically in the Pakistani population. The registry aims to fill a significant gap in data on prevalence and management in Asian populations, helping to tailor diagnosis and treatment to local needs. The study will enroll adult patients diagnosed with SLE by rheumatologists at Fauji Foundation Hospital Rawalpindi initially, with plans to expand to other centers across Pakistan. No treatments will be administered as part of the study since it is observational. Data collection follows a structured protocol and includes demographic details, disease characteristics, lab results, treatment history, and patient-reported outcomes using validated tools adapted to the local language. Patients will be followed over time with visits every three months. Participants will undergo routine clinic visits where trained healthcare professionals will collect and record data through medical records and patient questionnaires. The study monitors disease features, treatment patterns, outcomes, and factors influencing disease progression. Ethical approval and written informed consent are required, ensuring patient confidentiality and rights. The registry will contribute valuable insights to improve lupus care and research both nationally and internationally, with ongoing data collection planned for up to ten years.
CONDITIONS
Pakistan Arthritis and Connective Tissue Disease Network - Systemic Lupus Erythematosus
D
Dr. Shahida Perveen, FCPS, Rheumatology
D
Dr. Babur Salim, FCPS Rehumatology
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Foundation University Islamabad
Lead Sponsor
Fauji Foundation Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or telephone contact)
Duration - Up to 10 years
Participants attend regular clinic visits every three months. During these visits, healthcare professionals collect detailed information about disease characteristics, treatments, and patient-reported outcomes.
Visits every 3 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Megan R W Barber, Titilola Falasinnu, Rosalind Ramsey-Goldman...
https://pubmed.ncbi.nlm.nih.gov/36987602/Ernest Maningding, Maria Dall'Era, Laura Trupin...
https://pubmed.ncbi.nlm.nih.gov/31115180/Ioannis Parodis, Cristina Lanata, Dionysis Nikolopoulos...
https://pubmed.ncbi.nlm.nih.gov/38057256/Foundation University Islamabad
Lead Sponsor
Fauji Foundation Hospital
Collaborating Sponsor